Premium
“Accelerated ear‐age”: A new measure of chemotherapy‐induced ototoxicity
Author(s) -
Fligor Brian J.,
Krasker Jennie D.,
Villaluna Doojduen,
Krailo Mark,
Frazier A. Lindsay
Publication year - 2012
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.24169
Subject(s) - ototoxicity , medicine , blood cancer , normative , chemotherapy , audiology , cancer chemotherapy , hearing loss , scale (ratio) , pediatrics , cancer , surgery , cisplatin , philosophy , physics , quantum mechanics , epistemology
Currently, there are several different scales that grade chemotherapy‐induced ototoxicity. This report highlights how the implications of the conclusions drawn from each scale differ and compare these prior scales to a more functionally based scale developed at Children's Hospital Boston. Additionally, this report introduces the concept of “ear‐age,” akin to the age at which one would expect the observed decrease in hearing as a consequence of normative aging (but documented in a child or young adult following chemotherapy). Pediatr Blood Cancer 2012; 59: 947–949. © 2012 Wiley Periodicals, Inc.